LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/Citrus Based Biomaterial Helps Grow Bone
Biologics

Citrus Based Biomaterial Helps Grow Bone

December 5, 2018 2 min read Premium comments

Advertisement

Citrus Based Biomaterial Helps Grow Bone
Source: Wikimedia Commons and cogdogblog
Secondary#bonegrowth#citrate

Bones and fruit, in a blend which Penn State University researchers call “citrate,” can provide that little extra “oomph” required to grow bone more quickly and reliably.

According to the researchers, “citrate”—a natural and presumably organic product of bones and citrus fruit will “juice-up” stem cells which, in turn, will grow bone while also keeping the risk of rejection low.

A smoothie for bones.

According to a post from Rohit Bhisey, writing for Fact.MR Blog, this new “citrate” could help scientists around the world to develop biodegradable, citrate-releasing scaffolds to act as a template for bone development.

Lead researcher, Jian Yang, Ph.D., who is professor of biomedical engineering at Penn State, said that he and his team have been working on this for ten years. He told Rohit, “It is a known fact that 90% of organic citrate in the human body is found in the skeletal tissue, But there are no research studies that suggest the use of citrate as an important component to make biomaterial for bones.”

Dr. Yang and his team may well have a new biomimetic material on their hands.

Their work, “Citrate-based materials fuel human stem cells by metabonegenic regulation” is described in more detail in the latest issue of the journal Proceedings of the National Academy of Sciences.

One important discovery which was mentioned in Yang’s paper, was that he and his team did NOT see significant encapsulation or chronic inflammation from the “citrate” implant.

Advertisement

Lead author Chuying Ma, a doctoral student in Yang’s lab, told Bhisey that the team had discovered that the stem cell membrane has a transporter, which allows citrate to make its way into the cell and thereby pump up the cellular energy level.

To make new bone cells, Dr. Ma said, stem cells require more energy.

To be sure, she said, dosing and timing of supplying citrate to stem cells are critical.

Yang and Ma call the citrate effect “metabonegenic regulation.”

The researchers also discussed a second energy producing factor—phosphoserine, an amino acid.

Naturally, the team combined “citrate” with phosphoserine and are experimenting with in in rat models.

So far, the team is seeing evidence of new bone as early as one month after implant. The team is testing its new materials on cranial bone and femoral condyle bone defects.

Oranges and bones.

About time.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy